pcS-E626-C1C2
(Plasmid
#200162)
-
PurposeThis plasmid encodes EGFR targeting monobody (E626) fused to the extracellular vesicle binding domain (C1C2) of lactadherin for surface engineering extracellular vesicles.
-
Depositing Lab
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 200162 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcS-p88-C1C2
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameE626
-
Alt nameEGFR-targeting monobody
-
SpeciesH. sapiens (human)
-
Insert Size (bp)286
-
Mutationsequence adopted from doi: 10.1371/journal.pone.0138956
- Promoter CMV
-
Tag
/ Fusion Protein
- HA (N terminal on insert)
Cloning Information for Gene/Insert 1
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer N/A
- 3′ sequencing primer N/A (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert nameC1C2 domain of lactadherin
-
Alt namehC1C2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)963
-
GenBank IDNC_000015.10
-
Tag
/ Fusion Protein
- HIS (C terminal on insert)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcS-E626-C1C2 was a gift from Masako Harada (Addgene plasmid # 200162 ; http://n2t.net/addgene:200162 ; RRID:Addgene_200162) -
For your References section:
Design and Evaluation of Engineered Extracellular Vesicle (EV)-Based Targeting for EGFR-Overexpressing Tumor Cells Using Monobody Display. Komuro H, Aminova S, Lauro K, Woldring D, Harada M. Bioengineering (Basel). 2022 Jan 29;9(2). pii: bioengineering9020056. doi: 10.3390/bioengineering9020056. 10.3390/bioengineering9020056 PubMed 35200409